IP Library Patent Application 19305974
Patent Application
App. No. 19/305,974

Enzymatic RNA Capping Method

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/305,974
Abstract

Provided herein is a method for efficiently capping RNA in vitro. In some embodiments the capping reaction may be done at high temperature using Vaccinia capping enzyme or a variant thereof. In other embodiments, the capping reactions may comprise a capping enzyme from a large virus of amoeba, e.g., Faustovirus, mimivirus or moumouvirus, or a variant thereof. Compositions and kits for practicing the method are also provided.

Claims (46)

1 - 28 . (canceled)

29 . The method of claim 38 , wherein the uncapped target RNA is at least 200 nt in length.

30 . The method of claim 38 , wherein contacting further comprises increasing or decreasing the temperature to a second temperature of 37° C.-60° C., wherein the second temperature differs from the first temperature.

31 . The method of claim 38 , wherein (i), (ii), (iii), and (iv) are RNase-free and contacting optionally further comprises contacting (v) one or more RNase inhibitors.

32 . The method of claim 38 , further comprising synthesizing the uncapped target RNA using solid-phase oligonucleotide synthesis chemistry.

33 . The method of claim 38 , further comprising synthesizing the uncapped target RNA by contacting a DNA template encoding the uncapped RNA and a polymerase to produce the uncapped RNA.

34 . The method of claim 38 , wherein the methyl group donor is S-adenosyl methionine and contacting further comprises contacting (vi) a cap 2′O methyltransferase enzyme.

35 . The method of claim 38 , wherein the uncapped target RNA comprises one or more pseudouridines.

36 . The method of claim 38 , wherein contacting further comprises contacting (i), (ii), (iii), (iv) and optionally (v) in a single location.

37 . (canceled)

38 . A method for efficiently capping RNA in vitro, comprising:

contacting:

(i) an RNA sample comprising an uncapped target RNA;

(ii) a single-chain RNA capping enzyme that has RNA triphosphatase (TPase), guanylyltransferase (GTase) and guanine-N7 methyltransferase (N7 MTase) activities;

(iii) guanosine triphosphate (GTP) or modified GTP

(iv) a buffering agent; and

(v) a methyl group donor,

at a temperature of 23° C.-60° C., to form a capped target RNA.

39 . The method of claim 38 , wherein the single-chain RNA capping enzyme comprises amino acid sequence at least 90% identical to SEQ ID NO:5 and/or SEQ ID NO:6.

40 . The method of claim 38 , wherein the single-chain RNA capping enzyme comprises an amino acid sequence at least 90% identical to SEQ ID NO:11 and/or SEQ ID NO:12.

41 . The method according to claim 38 , further comprising monitoring the appearance of capped target RNA.

42 . A composition comprising:

(i) a polynucleotide;

(ii) a single-chain RNA capping enzyme that has RNA triphosphatase (TPase), guanylyltransferase (GTase) and guanine-N7 methyltransferase (N7 MTase) activities;

(iii) guanosine triphosphate (GTP);

(iv) a buffering agent; and

(v) a methyl group donor.

43 . The composition of claim 42 , wherein the composition has a temperature in the range of 23° C.-60° C.

44 . The composition of claim 42 , wherein the composition is RNase-free and optionally comprises (v) one or more RNase inhibitors.

45 . The composition of claim 42 , wherein the single-chain RNA capping enzyme comprises an amino acid sequence at least 90% identical to SEQ ID NO:5 and/or SEQ ID NO:6.

46 . The composition of claim 42 , wherein the single-chain RNA capping enzyme comprises an amino acid sequence at least 90% identical to SEQ ID NO:11 and/or SEQ ID NO:12.

47 . The composition of claim 42 , wherein the polynucleotide comprises a DNA template and the composition further comprises a bacteriophage polymerase and ribonucleotide triphosphates for transcribing the DNA template to form an uncapped target RNA.

48 . The composition of claim 42 , wherein the composition optionally comprises (vi) S-adenosyl methionine (SAM) and (vii) a cap 2′O methyltransferase enzyme.

49 . The composition of claim 42 , wherein the uncapped target RNA comprises one or more pseudouridines.

50 . The composition of claim 42 further comprising one or more detergents, dyes, solvents and/or preservatives.

51 . The composition of claim 42 , wherein the single-chain RNA capping enzyme comprises an amino acid sequence at least 95% identical to SEQ ID NO:11 and/or SEQ ID NO:12.

52 . A kit comprising:

a single-chain RNA capping enzyme that has RNA triphosphatase (TPase), guanylyltransferase (GTase) and guanine-N7 methyltransferase (N7 MTase) activities, wherein the enzyme is in a storage buffering agent; and

a reaction buffering agent.

53 . The kit of claim 52 , wherein the kit further comprises a bacteriophage polymerase and ribonucleotides, for transcribing a template polynucleotide encoding a target RNA.

54 . The kit of claim 52 , wherein the kit further comprises S-adenosyl methionine (SAM), cap 2′O methyltransferase enzyme (2′OMTase), or both SAM and 2′OMTase.

55 . The kit of claim 52 , wherein the single-chain RNA capping enzyme comprises an amino acid sequence at least 90% identical to SEQ ID NO:5 and/or SEQ ID NO:6.

56 . The kit of claim 52 , wherein the single-chain RNA capping enzyme comprises an amino acid sequence that is at least 90% identical to SEQ ID NO:11 or SEQ ID NO:12.

57 . The kit of claim 52 , wherein the kit further comprises one or more detergents, dyes, solvents and/or preservatives.

58 . The kit of claim 52 , wherein the single-chain RNA capping enzyme comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:11 or SEQ ID NO:12.

59 - 73 . (canceled)

Assignments (2)
SECURITY INTEREST Recorded May 29, 2026
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 074795/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2025
From: ROBB, G. BRETT; CHAN, SIU-HONG; ROY, BIJOYITA
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 072472/0189 →